Oxaliplatin Kabi 5 mg/ml concetrate for Solution for infusion
Country: Bulgaria
Language: Bulgarian
Source: Изпълнителна агенция по лекарствата
Patient Information leaflet
(PIL)
08-06-2017
Summary of Product characteristics
(SPC)
08-06-2017
Available from:
Fresenius Kabi Oncology Plc.
ATC code:
L01XA3
Dosage:
5 mg/ml concetrate for Solution for infusion
Product summary:
Oxaliplatin Kabi, 5 mg/ml concentrate for solution for infusion 50 mg/10ml; 100 mg/20 ml; 200mg/40ml;
Authorization date:
2015-01-09
